1. Context
2. Methods
2.1. Search Strategy
2.2. Inclusion and Exclusion Criteria
2.3. Study Selection
2.4. Data Extraction
2.5. Data Analysis
3. Results
| Organization or Country | World Health Organization Region | Number of Indicators | Number of Dimensions | Year |
|---|---|---|---|---|
| World Health Organization (29) | - | 34 | 6 | 2016 |
| Organization for Economic Co-operation and Development (30) | - | 26 | 3 | 2004 |
| Australia (31) | Western Pacific Region | 139 | 15 | 2005 |
| Australia (22) | 36 | 7 | 2012 | |
| European Union (18) | - | 99 | 10 | 2010 |
| European Union (32, 33) | - | 62 | 5 | 2005 |
| Canada (34) | Region of the Americas | 30 | 13 | 2012 |
| Canada (35) | Region of the Americas | 105 | 7 | 2005 |
| Iran (17) | Eastern Mediterranean Region | 40 | 7 | 2019 |
| Austria (36) | European Region | 30 | 5 | 2017 |
| Japan (37) | Western Pacific Region | 42 | 5 | 2018 |
| USA (38) | Region of the Americas | 54 | - | 2008 |
| USA (39) | Region of the Americas | 58 | 8 | 2013 |
| USA (40) | Region of the Americas | 30 | 3 | 2022 |
| Total | 785 | 94 |
| Dimensions | USA (39) | USA (40) | WHO-EMRO (29) | European Union (18) | European Union (32, 33) | Australia (31) | Australia (22) | Canada (34) | Canada (35) | OECD (30) | Iran (1) | Austria (36) | Japan (37) | Total a |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. Health promotion | * | * | 2 (15.4) b | |||||||||||
| 2. Preventive care | * | 1 (7.7) | ||||||||||||
| 3. Diagnosis and treatment | * | 1 (7.7) | ||||||||||||
| 4. Governance | * | * | * | 3 (23.1) | ||||||||||
| 5. Economic conditions | * | * | 2 (15.4) | |||||||||||
| 6. Staff development | * | * | * | 3 (23.1) | ||||||||||
| 7. Accessibility | * | * | * | * | * | * | * | * | * | * | * | 11 (84.6) | ||
| 8. Continuity | * | * | * | * | 4 (30.8) | |||||||||
| 9. Coordination | * | * | * | * | * | * | * | * | 8 (61.5) | |||||
| 10. Comprehensiveness | * | * | * | * | 4 (30.8) | |||||||||
| 11. Efficiency | * | * | * | * | * | 5 (38.5) | ||||||||
| 12. Patient centeredness | * | * | * | * | 4 (30.8) | |||||||||
| 13. Effectiveness | * | * | * | * | * | 5 (38.5) | ||||||||
| 14. Safety | * | * | * | * | * | * | 6 (46.2) | |||||||
| 15. Timeliness | * | * | 2 (15.4) | |||||||||||
| 16. Health status | * | 1 (7.7) | ||||||||||||
| 17. Health system infrastructure | * | * | * | 3 (23.1) | ||||||||||
| 18. Management of health information | * | 1 (7.7) | ||||||||||||
| 19. Acceptability | * | * | * | 3 (23.1) | ||||||||||
| 20. Equity | * | 1 (7.7) | ||||||||||||
| 21. Appropriateness | * | * | * | 3 (23.1) | ||||||||||
| 22. Quality | * | * | 2 (15.4) | |||||||||||
| 23. Communication | * | 1 (7.7) | ||||||||||||
| 24. Information | * | * | 2 (15.4) | |||||||||||
| 25. Finance | * | 1 (7.7) | ||||||||||||
| 26. Quality and safety | * | * | * | 3 (23.1) | ||||||||||
| 27. Responsiveness | * | 1 (7.7) | ||||||||||||
| 28. Clinician-patient partnership | * | 1 (7.7) | ||||||||||||
| 29. Technical quality | * | 1 (7.7) | ||||||||||||
| 30. Practice systems | * | 1 (7.7) | ||||||||||||
| 31. Understanding patient context | * | 1 (7.7) | ||||||||||||
| 32. Specific health problems | * | 1 (7.7) | ||||||||||||
| 33. Patient health records | * | 1 (7.7) | ||||||||||||
| 34. Collaborating with patients | * | 1 (7.7) | ||||||||||||
| 35. Education and training | * | 1 (7.7) | ||||||||||||
| 36. Facilities and access | * | 1 (7.7) | ||||||||||||
| 37. Equipment for comprehensive care | * | 1 (7.7) | ||||||||||||
| 38. Clinical support processes | * | 1 (7.7) | ||||||||||||
| Total | 8 | 3 | 6 | 11 | 4 | 15 | 7 | 13 | 7 | 3 | 7 | 5 | 5 | Sum = 94 |
Abbreviations: OECD, Organization for Economic Co-operation and Development; WHO, World Health Organization.
a Values are expressed as No. (%).
b Frequency is 2 (considered by two frameworks), so the relative frequency (percent) becomes: (2/13) × 100 = 15.4 %.
| Indicator’s Category | USA (38-40) | WHO-EMRO (29) | European Union (18, 32, 33) | Australia (22, 31) | Canada (34, 35) | OECD (30) | Iran (17) | Austria (36) | Japan (37) | Total a |
|---|---|---|---|---|---|---|---|---|---|---|
| 1. Nutrition and obesity | * | * | * | * | * | 5 (55.56) b | ||||
| 2. Physical activity | * | * | * | 3 (33.33) | ||||||
| 3. Smoking, alcohol, and substance abuse | * | * | * | * | * | * | * | 7 (77.78) | ||
| 4. Diabetes | * | * | * | * | * | * | * | * | * | 9 (100) |
| 5. HIV/AIDS | * | * | * | * | 4 (44.44) | |||||
| 6. Safe condition | * | * | * | * | 4 (44.44) | |||||
| 7. Vaccination | * | * | * | * | * | * | * | * | 8 (88.89) | |
| 8. Chronic heart disease | * | * | * | * | * | * | * | * | * | 9 (100) |
| 9. Respiratory/infectious disease | * | * | * | * | * | * | 6 (66.67) | |||
| 10. Hypertension | * | * | * | * | * | * | * | * | * | 9 (100) |
| 11. Population coverage | * | * | * | * | * | * | 6 (66.67) | |||
| 12. Community participation | * | * | * | * | * | * | 6 (66.67) | |||
| 13. Screening health risks | * | * | * | * | 4 (44.44) | |||||
| 14. Customer satisfaction (provider-client) | * | * | * | * | * | * | * | * | 8 (88.89) | |
| 15. Maternal and child health | * | * | * | * | * | * | 6 (66.67) | |||
| 16. Cancer screening | * | * | * | * | * | 5 (55.56) | ||||
| 17. Mental health | * | * | * | * | * | 5 (55.56) | ||||
| 18. Adverse event | * | * | * | * | * | * | 6 (66.67) | |||
| 19. Quality improvement program | * | * | * | * | 4 (44.44) | |||||
| 20. Health information management | * | * | * | * | * | * | * | 7 (77.78) | ||
| 21. Staff empowerment | * | * | * | * | * | * | 6 (66.67) | |||
| 22. Referral system | * | * | * | * | * | * | * | * | 8 (88.89) | |
| 23. Patient rights | * | * | * | * | * | * | * | 7 (77.78) | ||
| 24. Team working | * | * | * | * | 4 (44.44) | |||||
| 25. Appropriate prescribing | * | * | * | * | * | 5 (55.56) | ||||
| 26. Lipid disorders | * | * | * | 3 (33.33) | ||||||
| 27. Accreditation program | * | * | 2 (22.22) | |||||||
| 28. Financing and health expenditure | * | * | * | 3 (33.33) | ||||||
| 29. Teleconsultation | * | * | 2 (22.22) | |||||||
| 30. Home care | * | * | * | * | 4 (44.44) | |||||
| 31. Out-of-hours care | * | * | * | * | 4 (44.44) | |||||
| 32. Medication and equipment sufficiency | * | * | * | * | 4 (44.44) | |||||
| 33. Pregnancy care | * | * | * | * | 4 (44.44) | |||||
| 34. Medication safety | * | * | * | * | 4 (44.44) | |||||
| 35. Emergency/ambulatory care | * | * | * | * | * | 5 (55.56) | ||||
| 36. Waiting time | * | * | * | * | * | 5 (55.56) | ||||
| 37. Self-care | * | * | * | * | 4 (44.44) | |||||
| Total | 26 | 17 | 29 | 28 | 27 | 12 | 23 | 16 | 17 | Sum = 195 |
Abbreviations: OECD, Organization for Economic Co-operation and Development; WHO, World Health Organization.
a Values are expressed as No. (%).
b Frequency is 5 (considered by five frameworks). So, the relative frequency (percent) becomes: (5/9) × 100 = 55.56%.
